Cediranib (Standard)
Cediranib (Standard) is the analytical standard of Cediranib. This product is intended for research and analytical applications. Cediranib (AZD2171) is a highly potent, orally available VEGFR tyrosine kinase inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 288383-20-0
- Formule: C25H27FN4O3
- Masse moléculaire:450.51
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-10205
CediranibVEGFR2 Inhibitor -
HY-10065
AxitinibTyrosine Kinase Inhibitor -
HY-10208
PazopanibVEGFR Inhibitor -
HY-10260
VandetanibVEGFR2/3 Inhibitor -
HY-50904
NintedanibPDGFR/VEGFR/FGFR Inhibitor -
HY-13016
CabozantinibVEGFR2/MET Inhibitor -
HY-10201
SorafenibMultikinase Inhibitor -
HY-10981
LenvatinibVEGFR/FGFR Inhibitor -
HY-10331
RegorafenibMulti-kinase Inhibitor -
HY-10407
SU 5402Tyrosine Kinase Inhibitor -
HY-10374
SemaxinibFlk-1/KDR Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 288383-20-0
-
Masse moléculaire 450.51
-
Formule C25H27FN4O3
-
SMILES
FC1=C(OC2=C(C(C=C3OCCCN4CCCC4)=NC=N2)C=C3OC)C=CC5=C1C=C(C)N5
-
Synonyms
AZD2171 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Wedge SR, et al. AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res, 2005, 65(10), 4389-4400. [Content Brief]
[2]. Zhang L, et al. Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas. Sci Signal. 2015 Dec 8;8(406):ra125. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Cediranib (Standard) Related Classifications
HY-10205R Related Classifications
Powered by Bioz